No qualifying author-owned investment thesis was confirmed in this post.
no investment thesis
Comments2
▶ Full Post Text
RIME is set to gap up slightly pre-market, and it feels like early birds are stepping in before the open. No obvious headline catalyst on my screen, but I have seen this pattern before in micro-caps: price nudges up first, then the explanation shows up later (or it fades).
Two things make RIME worth monitoring today. First, the valuation is tiny (about $5M market cap), so any incremental attention can move it. Second, the reported revenue growth rate (over 1,200% in recent company summaries) keeps it on scanners even when the tape is quiet.
But I am not ignoring the downside risk: RIME is still below the 50-day and 200-day moving averages, which often acts like overhead supply. If you are thinking DCA, what level would make you stop adding vs reassess?
NFA.